Toth Financial Advisory Corp decreased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 11.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,532 shares of the biopharmaceutical company’s stock after selling 10,758 shares during the quarter. Toth Financial Advisory Corp’s […]
Kentucky Retirement Systems bought a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 169,435 shares of the biopharmaceutical company’s stock, valued at approximately $9,834,000. Other institutional investors have also recently modified […]
Arden Trust Co trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,239 shares of the biopharmaceutical company’s stock after selling 377 shares during the quarter. Arden Trust Co’s holdings in […]
Maple Capital Management Inc. boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,290 shares of the biopharmaceutical company’s stock after purchasing an additional 692 shares during the […]
Castellan Group lowered its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 87.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,000 shares of the biopharmaceutical company’s stock after selling 26,725 shares during the quarter. Castellan Group’s holdings in Bristol-Myers Squibb were […]